The Top Analysis for AbbVie, Inc. (ABBV)

The top analysis was written by Dividend Diplomats Blog titled Dividend Income Summary: Lanny’s November 2022 Summary

Is AbbVie, Inc. (ABBV) a buy?

Based on 7 suggestions, AbbVie, Inc.(ABBV) is recommended as a STRONG BUY at $138.96.

Are These Ratings Good?

Based on 7 ratings, the average Return is -0.21%.
The community has not been successfully rating this stock.

Forecast for AbbVie, Inc. (ABBV)

Based on the most recent price of $138.67,
the two year forecast for ABBV is $172.64.
The four year forecast is $206.62
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.